6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
8L40

Avenacy

About Avenacy

Avenacy is a U.S.-based specialty pharmaceutical company focused on supplying critical injectable medications used to treat patients in various medically supervised settings, from acute care hospitals to outpatient clinics and physician offices. Through a rigorous and optimized selection process, the Company is building out a pipeline of high-quality FDA approved injectable products in order to ensure a resilient portfolio that can meet the needs of today’s dynamic drug supply chain. With an experienced team, commitment to quality and reliability, and product offerings intended to facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential medications.

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    United States
  • On CPHI since:
    2022
  • Employees:
    25 - 49
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Finished Formulation products Distributor/Buyer
Contact info
  • 10 N. Martingale Road, Suite 225, 60173, Schaumburg, United States